市場調查報告書

全球Meperidine市場(2020-2026)

Global Meperidine Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949520
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球Meperidine市場(2020-2026) Global Meperidine Market 2020-2026
出版日期: 2020年06月03日內容資訊: 英文
簡介

在預測期內,□替啶市場預計將顯示穩定增長。□替啶由輝瑞公司提供,商標名為Demerol,是與嗎啡相似的阿片類鎮痛藥。因此,在大多數國家/地區都需要購買處方。廣泛用於緩解手術前後的中度至重度疼痛,以及用於其他治療。但是,該藥物不能用於治療長期或持續疼痛,而只能用於突然疼痛。

在預測期內,全球骨科手術的增長是市場增長的主要驅動力。此外,心血管,神經和外科手術的增加正在推動市場增長。但是,與藥物相關的副作用,如嘔吐,便秘,出汗,頭昏眼花,存在替代品以及患者開處方減少,是限制市場增長的一些因素。

全球□替啶市場是按應用和劑量類型細分的。通過應用,市場進一步細分為疼痛緩解和麻醉。按照給藥方式,市場分為口服藥和注射藥。按地區劃分,市場分為北美,歐洲,亞太地區和其他地區(RoW)。預計在預測期內,北美將佔有很大的市場份額。預計歐洲也將佔有很大的市場份額,德國,英國和法國將在該地區佔有很大的市場份額。此外,預計亞太地區將在預測期內顯示出顯著增長。醫療旅遊業的增加和醫療手術的增加是亞太地區市場增長的一些主要驅動力。

市場的主要參與者包括勃林格殷格翰國際有限公司,霓虹燈實驗室,輝瑞,Marin Clot plc,Hikuma Pharmaceuticals PLC等。市場參與者採用諸如併購,產品發佈,合作夥伴關係和協作之類的增長戰略來獲得市場競爭優勢。

該報告調查了全球□替啶市場,市場概況,市場增長因素和障礙的分析,市場規模趨勢以及按應用,管理類型和地區,競爭狀況以及主要公司的概況進行的預測。 系統信息,如市場機會。

內容

第1章報告概述

第2章市場概述和見解

  • 調查範圍
  • 分析師見解和當前市場趨勢
  • 規則與規定

第3章競爭情況

  • 公司份額分析
  • 主要策略分析
  • 主要公司分析

第4章市場決定因素

  • 動機
  • 抑制因子
  • 市場機會

第5章市場細分

  • 通過申請
    • 止痛
    • 麻醉
  • 按管理類型
      口語
    • 注射

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章公司簡介

  • Boehringer Ingelheim International GmbH
  • Neon Laboratories Ltd.
  • Pfizer Inc.
  • Mallinckrodt plc
  • Hikma Pharmaceuticals PLC
目錄
Product Code: OMR2021839

Global Meperidine Market Size, Share & Trends Analysis Report, By Application (Pain Relief, and Anesthesia), By Dosage type (Oral, and Injections) and Forecast, 2020-2026

The meperidine market is expected to show steady growth during the forecast period. It is offered under the brand name Demerol by Pfizer Inc. It is an opioid class analgesic drug, similar to morphine. Due to this, the drug needs a prescription to purchase in most of the countries. It is widely used to relieve a person from moderate to severe pain. Moreover, it is also used during or before surgery or other procedures. However, the drug cannot be used to treat long-term or on-going pain and is used only when the pain is sudden.

Rising cosmetic surgical procedures globally is a major factor for the growth of the market during the forecast period. Moreover, increasing cardiovascular, neurological, surgeries are also motivating the market growth. However, side effects related to the drug such as vomiting, constipation, sweating, lightheadedness, its alternatives available and decrease in the prescriptions to the patients are some of the restraining factors for the market growth.

The global meperidine market is divided on the basis of application and dosage type. Based on application, the market is further bifurcated into pain relief and anesthesia. By dosage type, the market is bifurcated into oral and injections. The market is also studied on the basis of geography. Based on geography, the global meperidine market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). During the forecast period, North America is expected to have a major market share. Europe is also expected to hold a considerable market share and Germany, UK, and France will hold a noticeable market share in the region. In addition, Asia-Pacific region is expected to show significant growth during the forecast period. Rising medical tourism, increasing medical surgeries, are some of the major factors motivating the market growth in Asia-Pacific.

Key players acting in the market include Boehringer Ingelheim International GmbH, Neon Laboratories Ltd., Pfizer Inc., Mallinckrodt plc, and Hikma Pharmaceuticals PLC. The market players are adopting growth strategies including mergers & acquisitions, product launches, and partnerships & collaborations to gain a competitive edge in the market.

Research Methodology

The market study of the global meperidine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to breakdown the market in various segments; derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Meperidine Market Research and Analysis, By Application
  • Global Meperidine Market Research and Analysis, By Dosage Type

The Report Covers:

  • Comprehensive research methodology of the Global Meperidine Market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Meperdine Market.
  • Insights about market determinants which are stimulating the Global Meperidine Market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdowns
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Meperidine Market by Application
    • 5.1.1. Pain Relief
    • 5.1.2. Anaesthesia
  • 5.2. Global Meperidine Market by Dosage type
    • 5.2.1. Oral
    • 5.2.2. Injections

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. France
    • 6.2.4. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Boehringer Ingelheim International GmbH
  • 7.2. Neon Laboratories Ltd.
  • 7.3. Pfizer Inc.
  • 7.4. Mallinckrodt plc
  • 7.5. Hikma Pharmaceuticals PLC

LIST OF TABLES

  • 1. GLOBAL MEPERIDINE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
  • 2. GLOBAL MEPERIDINE MARKET RESEARCH AND ANALYSIS BY DOSAGE TYPE, 2019-2026 ($ MILLION)
  • 3. NORTH AMERICAN MEPERIDINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 4. EUROPEAN MEPERIDINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 5. ASIA PACIFIC MEPERIDINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MEPERIDINE MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
  • 2. GLOBAL MEPERIDINE MARKET SHARE BY DOSAGE TYPE, 2019 VS 2026 (%)
  • 3. GLOBAL MEPERIDINE MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 4. US MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. REST OF EUROPE MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. INDIA MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. CHINA MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. JAPAN MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. REST OF ASIA-PACIFIC MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. REST OF THE WORLD MEPERIDINE MARKET SIZE, 2019-2026 ($ MILLION)